Pharmacology Monoclonal antibody against Nerve growth factor approved for chronic pain in patients with osteoahritis and chronic low back pain is: A Denosumab B Tanezumab C Alirocumab D Romosozumab 💡 Explanation Monoclonal antibody against Nerve growth factor approved for chronic pain in patients with osteoahritis and chronic low back pain is: ✓ Correct Answer: B. Tanezumab